ロード中...
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
NAFLD is a global epidemic. The prevalence of NAFLD is 20–30% in North America, northern Europe, Australia, Japan, India and China. It is crucial that patients with NAFLD receive an assessment for their risk of advanced fibrosis, which increases the risk of hepatocellular carcinoma and other complic...
保存先:
| 出版年: | Nat Rev Gastroenterol Hepatol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504909/ https://ncbi.nlm.nih.gov/pubmed/29463906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrgastro.2018.10 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|